SUPRAPHARM
Business purpose.
Mise en place et exploitation d'un groupement de pharmaciens titulaires d'officine. Toutes opérations commerciales, industrielles, mobilières et immobilière ou financières se rapportant directement ou indirectement ou pouvant être utiles à cet objet ou susceptibles d'en faciliter la réalisation.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Agents specialised in the sale of other particular products (46.18Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- 3 to 5 employees
- Created
- 1 Jan 2014
- Share capital
- 4,000.00 EUR
- Registered with the trade register
- 20 Jan 2014
- Financial year end
- 31/12
- Establishments
- 2
Directors
- Gilles SABAH 49 years old, 02/1977 Directeur general
- JEAN-EMMANUEL DIONNE 57 years old, 03/1969 Directeur general
- CYRIL BENDENOUN 55 years old, 09/1971 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- SELARL PHARMACIE DE L HORLOGE via JEAN-EMMANUEL DIONNE
- SELARL PHARMACIE DE LA BUSSIE via JEAN-EMMANUEL DIONNE
- SCI WRIGHT via JEAN-EMMANUEL DIONNE
- SCI JEAN JEAN via JEAN-EMMANUEL DIONNE
- S.P.F.P.L JED via JEAN-EMMANUEL DIONNE
- PHARMACIE DE LA LEVRIERE via CYRIL BENDENOUN
- FAMISABAH via Gilles SABAH
- GS INVEST via Gilles SABAH
Other companies at the same address
49 other company head offices are registered at this address.
Establishments
-
79943143200019 75020 PARIS
Financial strength
Financial score
72 / 100 B
Confidence: medium · computed on the financial year ended 31 Dec 2025
- Equity to assets (63.4 %)
- 22.5 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (343.5 %)
- 12.9 out of 20
- Debt (19.6 %)
- 11.5 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (12.9 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 0 € | — | 0 € | 1,530,991 € |
| 31 Dec 2023 | 0 € | — | 0 € | 1,481,008 € |
| 31 Dec 2022 | 0 € | — | 0 € | 1,110,109 € |
| 31 Dec 2021 | 0 € | — | 0 € | 1,200,395 € |
| 31 Dec 2020 | 0 € | — | 0 € | 1,209,698 € |
| 31 Dec 2019 | 0 € | first year on record | 0 € | 1,116,467 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la pharmacie d'officine du 3 décembre 1997. Etendue par arrêté du 13 août 1998 (JO du 8 septembre 1998).
IDCC 1996 · in force, extended · 1 establishment · declared in August 2026
Legal notices
-
Filing of accounts 21 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260136, annonce n 17132 · Proof of publication (PDF)
-
Amendment 6 Mar 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Nanterre
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20250046, annonce n 3706 · Proof of publication (PDF)
-
Filing of accounts 23 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240141, annonce n 12112 · Proof of publication (PDF)
-
Filing of accounts 23 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20240141, annonce n 12111 · Proof of publication (PDF)
-
Filing of accounts 10 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20240132, annonce n 7015 · Proof of publication (PDF)
-
Filing of accounts 14 Apr 2024
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20240074, annonce n 4188 · Proof of publication (PDF)
-
Amendment 18 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20240034, annonce n 2508 · Proof of publication (PDF)
-
Amendment 2 May 2023
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20230086, annonce n 3192 · Proof of publication (PDF)
-
Amendment 14 Mar 2023
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur l'activité.
BODACC B n 20230051, annonce n 3723 · Proof of publication (PDF)
-
Amendment 1 Mar 2023
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20230042, annonce n 3136 · Proof of publication (PDF)
-
Filing of accounts 29 Apr 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTERRE
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2019
BODACC C n 20210084, annonce n 9138 · Proof of publication (PDF)
Filings and accounts
- Formality 3 Mar 2025
Change history
- employee_range 03 → 02 4 Nov 2026
- employee_range 03 → 02 3 Nov 2026
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital 5000.00 → 4500.00 3 Oct 2026
- capital 4000.00 → 5000.00 2 Oct 2026
- capital (empty) → 4000.00 2 Oct 2026
- registered_address (empty) → 108 Rue Marius Aufan 92300 Levallois-Perret 2 Oct 2026
Frequently asked questions about SUPRAPHARM
- What is the SIREN number of SUPRAPHARM?
- The SIREN number of SUPRAPHARM is 799431432. Its intra-community VAT number is FR57799431432.
- Where is the head office of SUPRAPHARM?
- Head office address: 108 RUE MARIUS AUFAN, 92300 LEVALLOIS-PERRET.
- When was SUPRAPHARM founded?
- SUPRAPHARM was founded on 1 Jan 2014.
- What does SUPRAPHARM do?
- Its declared main activity is: Agents specialised in the sale of other particular products (NAF code 46.18Z).
- Who runs SUPRAPHARM?
- The officers listed in the register are Gilles SABAH (Directeur general), JEAN-EMMANUEL DIONNE (Directeur general), CYRIL BENDENOUN (President de SAS).
- What is the revenue of SUPRAPHARM?
- The latest published revenue is 0 €, for the 2025 financial year.
- How many employees does SUPRAPHARM have?
- The declared headcount is 3 to 5 employees. Insee data for 2024.
- Is SUPRAPHARM subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.